Tanaka K, Koseki M, Kato H, Miyashita K, Okada T, Kanno K, Saga A, Chang J, Omatsu T, Inui H, Ohama T, Nishida M, Yamashita S, Sakata Y (2022)
Anti-GPIHBP1 Antibody-Positive Autoimmune Hyperchylomicronemia and Immune Thrombocytopenia
J Atheroscler Thromb

Yamashita S, Kawakami Y, Sato H, Sugitani S, Goto M, Kato N (2019)
Contribution of intestinal dipeptidyl peptidase-4 inhibition for incretin-dependent improved glucose tolerance in mice
European Journal of Pharmacology

Gabrusiewicz K, Li X, Wei J, Hashimoto Y, Marisetty AL, Ott M, Wang F, Hawke D, Yu J, Healy LM, Hossain A, Akers JC, Maiti SN, Yamashita S, Shimizu Y, Dunner K, Zal MA, Burks JK, Gumin J, Nwajei F, Rezavanian A, Zhou S, Rao G, Sawaya R, Fuller GN, Huse JT, Antel JP, Li S, Cooper L, Sulman EP, Chen C, Geula C, Kalluri R, Zal T, Heimberger AB (2018)
Glioblastoma stem cell-derived exosomes induce M2 macrophages and PD-L1 expression on human monocytes
Oncoimmunology 7: e1412909

Kurozumi A, Okada Y, Arao T, Kobayashi T, Masuda D, Yamashita S, Tanaka Y (2018)
Comparison of effects of anagliptin and alogliptin on serum lipid profile in type 2 diabetes mellitus patients
J Diabetes Investig 9: 360

Dimitriou PS, Denesyuk AI, Takahashi S, Yamashita S, Johnson MS, Nakayama T, Denessiouk K (2017)
Alpha/beta-hydrolases: A unique structural motif coordinates catalytic acid residue in 40 protein fold families
Proteins 85: 1845

Hirano T, Yamashita S, Takahashi M, Hashimoto H, Mori Y, Goto M (2016)
Anagliptin, a dipeptidyl peptidase-4 inhibitor, decreases macrophage infiltration and suppresses atherosclerosis in aortic and coronary arteries in cholesterol-fed rabbits
Metabolism 65: 893

Kuroda M, Holleboom AG, Stroes ES, Asada S, Aoyagi Y, Kamata K, Yamashita S, Ishibashi S, Saito Y, Bujo H (2014)
Lipoprotein subfractions highly associated with renal damage in familial lecithin:cholesterol acyltransferase deficiency
Arterioscler Thromb Vasc Biol 34: 1756

Ohara K, Unno H, Oshima Y, Hosoya M, Fujino N, Hirooka K, Takahashi S, Yamashita S, Kusunoki M, Nakayama T (2014)
Structural Insights into the Low pH Adaptation of a Unique Carboxylesterase from Ferroplasma: Altering the pH optima of two carboxylesterases
Journal of Biological Chemistry 289: 24499

Gotoda T, Shirai K, Ohta T, Kobayashi J, Yokoyama S, Oikawa S, Bujo H, Ishibashi S, Arai H, Yamashita S, Harada-Shiba M, Eto M, Hayashi T, Sone H, Suzuki H, Yamada N (2012)
Diagnosis and management of type I and type V hyperlipoproteinemia
J Atheroscler Thromb 19: 1

Kotoh K, Fukushima M, Horikawa Y, Yamashita S, Kohjima M, Nakamuta M, Enjoji M (2012)
Serum albumin is present at higher levels in alcoholic liver cirrhosis as compared to HCV-related cirrhosis
Exp Ther Med 3: 72

Kato N, Oka M, Murase T, Yoshida M, Sakairi M, Yamashita S, Yasuda Y, Yoshikawa A, Hayashi Y, Makino M, Takeda M, Mirensha Y, Kakigami T (2011)
Discovery and pharmacological characterization of N-[2-({2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl}amino)-2-methylpropyl]-2-methyl pyrazolo[1,5-a]pyrimidine-6-carboxamide hydrochloride (anagliptin hydrochloride salt) as a potent and selective DPP-IV inhibitor
Bioorganic & Medicinal Chemistry 19: 7221

Kato N, Oka M, Murase T, Yoshida M, Sakairi M, Yakufu M, Yamashita S, Yasuda Y, Yoshikawa A, Hayashi Y, Shirai M, Mizuno Y, Takeuchi M, Makino M, Takeda M, Kakigami T (2011)
Synthesis and pharmacological characterization of potent, selective, and orally bioavailable isoindoline class dipeptidyl peptidase IV inhibitors
Org Med Chem Lett 1: 7

Shimamura M, Matsuda M, Yasumo H, Okazaki M, Fujimoto K, Kono K, Shimizugawa T, Ando Y, Koishi R, Kohama T, Sakai N, Kotani K, Komuro R, Ishida T, Hirata K, Yamashita S, Furukawa H, Shimomura I (2007)
Angiopoietin-like protein3 regulates plasma HDL cholesterol through suppression of endothelial lipase
Arterioscler Thromb Vasc Biol 27: 366

Maruyama T, Yamashita S, Matsuzawa Y, Bujo H, Takahashi K, Saito Y, Ishibashi S, Ohashi K, Shionoiri F, Gotoda T, Yamada N, Kita T (2004)
Mutations in Japanese subjects with primary hyperlipidemia--results from the Research Committee of the Ministry of Health and Welfare of Japan since 1996
J Atheroscler Thromb 11: 131

Saika Y, Sakai N, Takahashi M, Maruyama T, Kihara S, Ouchi N, Ishigami M, Hiraoka H, Nakamura T, Yamashita S, Matsuzawa Y (2003)
Novel LPL mutation (L303F) found in a patient associated with coronary artery disease and severe systemic atherosclerosis
European Journal of Clinical Investigation 33: 216

Toyoda T, Sugimoto H, Yamashita S (1999)
Sequence, expression in Escherichia coli, and characterization of lysophospholipase II
Biochimica & Biophysica Acta 1437: 182

Sugimoto H, Hayashi H, Yamashita S (1996)
Purification, cDNA cloning, and regulation of lysophospholipase from rat liver
Journal of Biological Chemistry 271: 7705

Endoh M, Yamashita S, Taira N (1982)
Positive inotropic effect of amrinone in relation to cyclic nucleotide metabolism in the canine ventricular muscle
Journal of Pharmacology & Experimental Therapeutics 221: 775

Endoh M, Yamashita S (1981)
Differential responses to carbachol, sodium nitroprusside and 8-bromo-guanosine 3',5'-monophosphate of canine atrial and ventricular muscle
British Journal of Pharmacology 73: 393

Endoh M, Yamashita S (1980)
Adenosine antagonizes the positive inotropic action mediated via beta-, but not alpha-adrenoceptors in the rabbit papillary muscle
European Journal of Pharmacology 65: 445